The impact of menopause on bone, zoledronic acid, and implications for breast cancer growth and metastasis

Recent data from the AZURE, ABCSG-12, and ZO-FAST clinical trials have challenged our understanding of the potential anticancer activity of zoledronic acid (ZOL). Although the results of these studies may appear to be conflicting on the surface, a deeper look into commonalities among the patient pop...

Descripción completa

Detalles Bibliográficos
Autores principales: Hadji, P., Coleman, R., Gnant, M., Green, J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2012
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3477882/
https://www.ncbi.nlm.nih.gov/pubmed/22730099
http://dx.doi.org/10.1093/annonc/mds169

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3477882/
https://www.ncbi.nlm.nih.gov/pubmed/22730099
http://dx.doi.org/10.1093/annonc/mds169

Ejemplares similares